Metabolic-Fit / 100
TeleCare Spot review
Publishes per-program floors — from $299 semaglutide, from $399 tirzepatide — then adds a $79 consultation fee that is only "may be applied" toward treatment, and never names its operating company.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
TeleCare Spot at a glance
- Semaglutide
- $299/mo
- Tirzepatide
- $399/mo
- Coverage
- Not stated on the site
- Brand-name
- Compounded only
How we scored TeleCare Spot
Every factor comes from TeleCare Spot's own published pricing, disclosures and oversight, and the six combine into the 34/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- telecarespot.com
Semaglutide from $299 and tirzepatide from $399, plus a $79 consultation fee that is only conditionally credited back. Both prices are floors with no published ceiling, and the site never names the company behind it.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $299 | InjectionRead live August 21, 2026 on /weight-loss/: "From $299 /month". |
| Compounded tirzepatide | $399 | InjectionRead live August 21, 2026: "From $399 /month". |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what TeleCare Spot's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- Publishes distinct per-program rates rather than one vague range
- Offers a lower-cost phentermine program from $189/month alongside the GLP-1 options
- Intake is a standard IntakeQ form and responded normally when checked
The caveats
- A separate $79 one-time consultation fee, described only as one that MAY be applied toward treatment
- Both GLP-1 prices are prefixed "From" with no published ceiling
- No operating entity named anywhere on the public site
- No state list published
TeleCare Spot for mothers: our verdict
Publishes per-program floors — from $299 semaglutide, from $399 tirzepatide — then adds a $79 consultation fee that is only "may be applied" toward treatment, and never names its operating company. It runs about $299/month — a premium to the category, so the extras have to earn it.
We weigh TeleCare Spot the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.
What TeleCare Spot costs, in full
- Compounded semaglutide — Injection: $299/mo
- Compounded tirzepatide — Injection: $399/mo
For context, the typical ongoing price across our roster is around $179/month, so TeleCare Spot sits at the premium end.
On that last point TeleCare Spot is no help: it doesn't break down what the monthly figure covers — whether the provider visit, shipping and any lab work are inside it or billed separately. Ask before you pay, because that answer is what decides whether a mid-range price is actually mid-range.
The medications TeleCare Spot prescribes
TeleCare Spot prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where TeleCare Spot fits — and where it doesn't — for mothers
A good fit if…
- switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.
Look elsewhere if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.
Oversight, safety, and what we could verify
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
One line that applies to every provider on this site: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
TeleCare Spot is a reasonable option — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Someone who wants a phentermine option alongside the GLP-1 lane and will confirm whether the $79 consultation fee is actually credited before paying it.
Alternatives to TeleCare Spot
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing TeleCare Spot
Head-to-head & alternatives
TeleCare Spot, answered
- How much does TeleCare Spot cost?
- At last review, TeleCare Spot's lowest ongoing compounded rate was about $299 a month — $299/mo for semaglutide, $399/mo for tirzepatide. This market re-prices often, so check the current all-in figure at the source before committing.
- Is TeleCare Spot safe to use while breastfeeding?
- Nothing in this class — compounded or brand — has been established as safe in pregnancy or lactation, and every label advises against use. TeleCare Spot is not an exception to that. Plan a GLP-1 for after weaning and settle the timing with your own clinician.
- Does TeleCare Spot offer both semaglutide and tirzepatide?
- Yes — TeleCare Spot offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does TeleCare Spot rank for mothers?
- TeleCare Spot scores 34/100 on our Metabolic-Fit Score and sits at #255. That score is a weighted read of six things mothers actually have to care about. CoreAge Rx currently leads it — see how they compare.
Pricing, states and verification reflect TeleCare Spot's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.